MDxHealth is trading at $0.67, up 10.91%, with no clear company-specific catalyst identified for October 13, 2026.

  • The 2026 press-release archive lists no announcement for October 13; the latest release is dated August 13.
  • Healthcare-sector weakness is negative context rather than an evident explanation for the sharp rise, while supplied major-index moves are modest.